Wellington Management Group LLP Revolution Medicines, Inc. Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 11,401,394 shares of RVMD stock, worth $629 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

11,401,394

Previous 13,660,196 16.54%

Holding current value

$629 Million

Previous $530 Million 2.56%

% of portfolio

0.09%

Previous 0.1%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$36.92 - $47.94 $83.4 Million - $108 Million	-2,258,802 Reduced 16.54%	11,401,394 $517 Million
Q2 2024 Aug 13, 2024	SELL	$30.14 - $40.68 $31.8 Million - $42.9 Million	-1,054,530 Reduced 7.17%	13,660,196 $530 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $391 Million - $494 Million	14,714,726 New	14,714,726 $474 Million
Q4 2023 Feb 12, 2024	BUY	$18.35 - $34.12 $273 Million - $508 Million	14,882,086 New	14,882,086 $427 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $7.12 Million - $9.91 Million	282,786 Added 2.75%	10,572,475 $293 Million
Q2 2023 Aug 14, 2023	SELL	$20.28 - $27.0 $2.75 Million - $3.66 Million	-135,679 Reduced 1.3%	10,289,689 $275 Million
Q1 2023 May 12, 2023	BUY	$20.76 - $30.09 $32.2 Million - $46.7 Million	1,551,394 Added 17.48%	10,425,368 $226 Million
Q4 2022 Feb 13, 2023	BUY	$17.68 - $25.53 $26.4 Million - $38.1 Million	1,492,795 Added 20.22%	8,873,974 $211 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $21.2 Million - $31.5 Million	1,212,177 Added 19.65%	7,381,179 $146 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $30.3 Million - $56.6 Million	2,085,013 Added 51.05%	6,169,002 $120 Million
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $7.39 Million - $11.3 Million	-426,906 Reduced 9.46%	4,083,989 $104 Million
Q4 2021 Feb 11, 2022	SELL	$24.35 - $33.7 $638,140 - $883,175	-26,207 Reduced 0.58%	4,510,895 $114 Million
Q3 2021 Nov 15, 2021	SELL	$23.95 - $33.41 $25 Million - $34.8 Million	-1,041,946 Reduced 18.68%	4,537,102 $125 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $48.1 Million - $78.7 Million	1,658,400 Added 42.3%	5,579,048 $177 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $137 Million - $201 Million	3,688,457 Added 1588.54%	3,920,648 $180 Million
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $855,946 - $1.29 Million	28,352 Added 13.91%	232,191 $9.19 Million
Q3 2020 Nov 16, 2020	SELL	$22.61 - $34.8 $1.78 Million - $2.75 Million	-78,902 Reduced 27.91%	203,839 $7.09 Million
Q2 2020 Aug 14, 2020	SELL	$19.65 - $39.34 $1.06 Million - $2.12 Million	-53,924 Reduced 16.02%	282,741 $8.93 Million
Q1 2020 May 14, 2020	BUY	$20.0 - $34.08 $6.73 Million - $11.5 Million	336,665 New	336,665 $7.38 Million

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.83B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Revolution Medicines, Inc. Transaction History